•
Dec 31, 2024

iTeos Therapeutics Q4 2024 Earnings Report

Expected Revenue:$0
-100.0% YoY
Expected EPS:-$1.02
+1.0% YoY
Total Revenue
$0
0
Gross Profit
-$322K
Previous year: -$233K
+38.2%
Cash and Equivalents
$495M
Previous year: $532M
-7.0%
Free Cash Flow
$5.35M
Previous year: -$15.2M
-135.3%
Total Assets
$687M
Previous year: $668M
+2.9%

iTeos Therapeutics

iTeos Therapeutics